HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer |
| |
Authors: | Yokomizo Akira Koga Hirofumi Kinukawa Naoko Tsukamoto Taiji Hirao Yoshihiko Akaza Hideyuki Mori Mitsuru Naito Seiji |
| |
Affiliation: | Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. |
| |
Abstract: | BACKGROUND: HPC2/ELAC2 gene was identified by linkage analysis from familial prostate cancer (Pca) patients in USA. To determine the association of HPC2/ELAC2 gene with Japanese sporadic Pca, we performed a case-control study focused on two missense polymorphisms. METHODS: We genotyped the two polymorphic sites of Ser217Leu and Ala541Thr in sporadic Japanese Pca patients (n = 285) and matched controls (n = 233). Controls were unrelated Japanese outpatients who had no history of any cancer and normal PSA level (less than 4.0 ng/ml). Statistical analyses were performed by Mann-Whitney's U-test, Fisher's exact test, and logistic regression analysis. RESULTS: We observed a significantly higher frequency of the Thr allele at 541 polymorphic site in Pca patients (8.4%) compared to the control group (2.1%) (P = 0.0030, Odds Ratio (OR) = 4.02, 95% CI = 1.50-10.8). However, this SNP does not correlate with clinical stage, PSA level, Gleason score of biopsies or age at diagnosis. No association was identified at Ser217Leu polymorphic site. CONCLUSIONS: Our results indicate that Thr allele at 541 in HPC2/ELAC2 has strong significance in the predisposition of sporadic Pca in Japan. This polymorphism can be useful to predict the personal Pca risk, which lead the effective screening of Pca. |
| |
Keywords: | HPC2/ELAC2 polymorphism prostate cancer SNP |
本文献已被 PubMed 等数据库收录! |
|